McKesson Corporation (MCK) Extends CVS Distribution Agreement to 2032

McKesson signed an agreement in principle to extend its pharmaceutical distribution partnership with CVS Health through June 2032 and reaffirmed FY2027 adjusted EPS guidance of $44.20—$45.00 and a long-term adjusted EPS growth rate of 13%—16%.Material DetailsContext by AI AnalystThis is a late conf…